Pharmaceutical and biomedical potential of surface engineered dendrimers

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 24, Issue 3, 2007, Pages 257-306

  Satija, Jitendra ^a   Gupta, Umesh ^a   Jain, Narendra Kumar ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Biomimetic; Cytotoxicity; Functional nanoconstructs; Gene transfection; Immunogenicity; Solubilization

Indexed keywords

AMINE; ARGININE; CARBOHYDRATE; CATION; CITRIC ACID; CONTRAST MEDIUM; DENDRIMER; DIAGNOSTIC AGENT; DRUG CARRIER; LIGAND; LIPID; MACROGOL; POLYESTER; SIALIC ACID; STEROID;

ALZHEIMER DISEASE; ANTIBACTERIAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTIFICIAL ORGAN; BIOCOMPATIBILITY; BIOLOGICAL ACTIVITY; BIOMEDICAL ENGINEERING; BIOMIMETICS; BIOSAFETY; CELL MEMBRANE; COLLOID; CYTOTOXICITY; DIAGNOSTIC PROCEDURE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG RELEASE; DRUG STRUCTURE; DRUG TARGETING; ENCAPSULATION; GENE DELIVERY SYSTEM; GENETIC TRANSFECTION; HEMOLYSIS; IMMUNOGENICITY; LIGAND BINDING; MEMBRANE TRANSPORT; MICELLE; MOLECULAR WEIGHT; NONHUMAN; PHYSICAL CHEMISTRY; RETICULOENDOTHELIAL SYSTEM; REVIEW; SHELF LIFE; SOLUBILIZATION; STRUCTURE ANALYSIS; SURFACE MODIFICATION; SURFACE PROPERTY; TREATMENT PLANNING;

EID: 38049016511     PISSN: 07434863     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevTherDrugCarrierSyst.v24.i3.20     Document Type: Review

References (196)

1. Tomalia DA, Fréchet JMJ. A brief historical perspective. In: Fréchet JMJ, Tomalia DA, editors. Dendrimers and other dendritic polymers. 1st ed. New York: Wiley; 2001. p. xxvii-xxxix.
2. Buhleier E, Wehner W, Vogtle F. Cascade and nonskid-chain-like syntheses of molecular cavity topologies. Synthesis. 1978;155-58.
3. Tomalia DA, Baker H, Dewald JR, Hall M, Kallos G, Martin S, Roeck J, Ryder J, Smith P. A new class of polymers: starburst dendritic molecules. Polym J. 1985;17:117-32.
4. Newkome GR, Moorefield CN, Baker GR, Saunders MJ, Grossman SH. Unimolecular micelles. Angew Chem Int Ed. 1991;30:1178-80.
5. Fréchet JMJ, editor. Dendrimers and supramolecular chemistry. Proc Nat Acad Sci USA. 2002;99:4782-87.
6. Naylor AM, Goddard WA, Kiefer GE, Tomalia DA. Starburst dendrimers: molecular shape control. J Am Chem Soc. 1989;111:2339-41.
7. Hawker J, Wooley KL, Fréchet JMJ. Unimolecular micelles and globular amphiphiles: Dendritic macromolecules as novel recyclable solubilization agents. J Chem Soc Perkin Trans 1. 1993;1:1287-97.
8. Newkome GR, Young JK, Baker GR, Potter RL, Audoly L, Cooper D, Weis CD, Morris K, Johnson CS. Cascade polymers: pH dependence of hydrodynamic radii of acid terminated dendrimers. Macromolecules. 1993;26:2394-6.
9. Jansen JFGA, De Berg EMM, Meijer EW. Encapsulation of guest molecules into a dendritic box. Science. 1994;266:1226-29.
10. Jansen JFGA, Meijer EW, De Berg EMM. The dendritic box: Shape-selective liberation of encapsulated guests. J Am Chem Soc. 1995;117:4417-8.
11. Stevelmans S, Hest JCMV, Jansen JFGA, Van Boxtel DAFG, De Berg EMM, Meijer EW. Synthesis, characterization and guest-host properties of inverted unimolecular dendritic micelles. J Am Chem Soc. 1996;118:7398-9.
12. Baars MWPL, Froehling PE, Meijer EW. Liquid-liquid extractions using poly(propylene imine) dendrimers with an apolar periphery. Chem Commun. 1997;3:1959-60.
13. Sideratou Z, Tsiourvas D, Paleos CM. Quaternized poly(propylene imine) dendrimers as novel pH-sensitive controlled-release systems. Langmuir. 2000;16:1766-9.
14. Newkome GR, Yao Z, Baker GR, Gupta VK. Cascade molecules: A new approach to micelles, arborol. J Org Chem. 1985;50:2003-4.
15. Roy R, Zanini D, Meunier SJ, Romanowska A. Solid-phase synthesis of dendritic sialoside inhibitors of influenza A virus haemagglutinin. J Chem Soc Chem Commun. 1993;1869-72.
16. Ashton PR, Boyd SE, Bown CL, Jayaraman N, Nepogodiev SA, Stoddart JF. A convergent synthesis of carbohydrate-containing dendrimers. Chem Eur J. 1996;2:1115-28.
17. Ballauff M. Dendrimers III: design, dimension, function. Topics Curr Chem. 2001;212:177-94.
18. Fischer D, Bieber T, Li Y, Elsasser HP, Kissel T. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: Effect of molecular weight on transfection and cytotoxicity. Pharm Res. 1999;16:1273-9.
19. Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T. In vitro cytotoxicity testing of polycations: Influence of polymer structure on cell viability and haemolysis. Biomaterials. 2003;24:1121-31.
20. Wiwattanapatapee R, Gomez BC, Malik N, Duncan R. Anionic PAMAM dendrimers rapidly cross adult rat intestine in vitro: a potential oral delivery system? Pharm Res. 2000;17:991-8.
21. Tajarobi F, El-Sayed M, Rege BD, Polli JE, Ghandehari H. Transport of polyamidoamine dendrimers across Madin-Darby canine kidney cells. Int J Pharm. 2001;215:263-7.
22. El-Sayed M, Rhodes CA, Ginski M, Ghandehari H. Transport mechanism(s) of poly (amidoamine) dendrimers across Caco-2 cell monolayers. Int J Pharm. 2003;265:151-7.
23. Manunta M, Tan PH, Sagoo P, Kashefi K, George AJT. Gene delivery by dendrimers operates via a cholesterol dependent pathway. Nucleic Acids Res. 2004;32:2730-9.
24. Kojima C, Kono K, Maruyama K, Takagishi T. Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconj Chem. 2000;11:910-7.
25. Bhadra D, Bhadra S, Jain S, Jain NK. A PEGylated dendritic nanoparticulate carrier of fluorouracil. Int J Pharm. 2003;257:111-24.
26. Bhadra D, Bhadra S, Jain NK. PEGylated lysine based copolymeric dendritic micelles for solubilization and delivery of artemether. J Pharm Pharmceut Sci. 2005;8:467-82.
27. Kumar PV, Agashe H, Dutta T, Jain NK. PEGylated dendritic architecture for development of a prolonged drug delivery system for an antitubercular drug. Curr Drug Delivery. 2007;4:11-9.
28. Kumar PV, Asthana A, Dutta T, Jain NK. Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers. J Drug Targeting. 2006;14:546-56.
29. Dutta T, Jain NK. Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly(propylene imine) dendrimer. Biochim Biophys Acta. 2007;1770:681-6.
30. Agrawal P, Gupta U, Jain NK. Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate. Biomaterials. 2007;28:3349-59.
31. Namazi H, Adeli M. Dendrimers of citric acid and poly(ethylene glycol) as the new drug-delivery agents. Biomaterials. 2005;26:1175-83.
32. Chandrasekar D, Sistla R, Ahmad FJ, Khar RK, Diwan PV. The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats. Biomaterials. 2007;28:504-12.
33. Agashe HB, Dutta T, Garg M, Jain NK. Investigations on the toxicological profile of functionalized fifth-generation poly(propylene imine) dendrimer. J Pharm Pharmacol. 2006;58:1491-98.
34. Patri AK, Myc A, Beals J, Thomas TP, Bander NH, Baker JR. Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy. Bioconj Chem. 2004;15:1174-81.
35. Milhem OM, Myles C, McKeown NB, Attwood D, D'Emanuele A. Polyamidoamine starburst dendrimers as solubility enhancers. Int J Pharm. 2000;197:239-41.
36. Kolhe P, Misra E, Kannan RM, Kannan S, Lai ML. Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. Int J Pharm. 2003;259:143-60.
37. Chauhan AS, Sridevi S, Chalasani KB. Dendrimer-mediated transdermal delivery: Enhanced bioavailability of indomethacin. J Control Rel. 2003;90:335-43.
38. Ooya T, Lee J, Park K. Effects of ethylene glycol based grafts, star-shaped and dendritic polymers on solubilization and controlled release of paclitaxel. J Control Rel. 2003;93:121-7.
39. Yiyun C, Tongwen X. Solubility of nicotinic acid in polyamidoamine dendrimer solutions. Eur J Med Chem. 2005;40:1384-89.
40. Gupta U, Agashe HB, Asthana A, Jain NK. Dendrimers: novel polymeric nanoarchitectures for solubility enhancement. Biomacromolecules. 2006;7:649-58.
41. Gupta U, Agashe HB, Jain NK. Polypropylene imine dendrimer mediated solubility enhancement: Effect of pH and functional groups of hydrophobes. J Pharm Pharmaceut Sci. 2007;10:358-67.
42. Latallo JFK, Bielinska AU, Johnson J, Spindler R, Tomalia DA, Baker JR. Efficient transfer of genetic material into mammalian cells by using starburst polyamidoamine dendrimers. Proc Natl Acad Sci USA. 1996;93:4897-902.
43. Tang MX, Redemann CT, Szoka FC. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconj Chem. 1996;7:703-14.
44. Tomlinson E, Rolland AP. Controllable gene therapy: Pharmaceutics of non-viral gene delivery systems. J Control Rel. 1996;39:357-72.
45. Esfand R, Tomalia DA. Poly(amidoamine) (PAMAM) dendrimers: From biomimicry to drug delivery and biomedical applications. Drug Discov Today. 2001;6:427-36.
46. Dufe C, Uchegbu IF, Schatzlein AG. Dendrimers in gene delivery. Adv Drug Deliv Rev. 2005;57:2177-202.
47. Hughes JA, Aronsohn AI, Avrutskaya AV, Juliano RL. Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides. Pharm Res. 1996;13:404-10.
48. Bielinska A, Latallo JFK, Johnson J, Tomalia DA, Baker JR. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acids Res. 1996;24:2176-82.
49. Khopade AJ, Chauhan AS, Khopade SA, Jain NK, editors. Studies on PAMAM dendrimer-copper(II)-6 mercaptopurine ternary complex. Proceedings of 26th International Symposium of Controlled Release Bioactive Material; 1999 June 20-25; Boston, Massachusetts, USA. Control Release Society Inc.; 769-70.
50. Malik N, Evagorou EG, Duncan R. Dendrimer-platinate: a novel approach to cancer chaemotherapy. Anti Cancer Drugs. 1999;10:767-76.
51. Yoo H, Sazani P, Juliano RL. PAMAM dendrimers as delivery agents for antisense oligonucleotides. Pharm Res. 1999;16:1799-804.
52. Fréchet J.M.J. Designing dendrimers for drug delivery. Pharm Sci Technol Today. 2000;2:393-401.
53. Lebedeva I, Benimetskaya L, Stein CA, Vilenchik M. Cellular delivery of antisense oligonucleotides. Eur J Pharm Biopharm. 2000;50:101-19.
54. Jaaskelainen I, Peltola S, Honkakoski P, Monkkonen J, Urtti A. A lipid carrier with a membrane active component and a small complex size are required for efficient cellular delivery of anti-sense phosphorothioate oligonucleotides. Eur J Pharm Sci. 2000;10:187-93.
55. Shah DS, Sakthivel T, Toth I, Florence AT, Wilderspin AF. DNA transfection and transfected cell viability using amphipathic asymmetric dendrimers. Int J Pharm. 2000;208:41-8.
56. Tripathi PK, Khopade AJ, Nagaich S, Shrivastava S, Jain S, Jain NK. Dendrimer grafts for delivery of 5-fluorouracil. Pharmazie. 2002;57:261-4.
57. Aulenta F, Hayes W, Rannard S. Dendrimers: a new class of nanoscopic containers and delivery devices. Eur Poly J. 2003;39:1741-71.
58. Boas U, Heegaard PMH. Dendrimers in drug research. Chem Soc Rev. 2004;33:43-63.
59. Asthana A, Chauhan AS, Diwan PV, Jain NK. Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled site-specific delivery of acidic anti-inflammatory active ingredient. AAPS Pharm Sci Tech. 2005;6:E536-42.
60. Dass CR. Vehicles for oligonucleotide delivery to tumours. J Pharm Pharmacol. 2002;54:3-27.
61. Dutta T, Agashe HB, Kumar PV, Joshi M, Jain NK. Dendrosome-based gene delivery. J Exp Nanosci. 2006;1:235-48.
62. Lee CC, MacKay JA, Fréchet JMJ, Szoka FC. Designing dendrimers for biological applications. Nat Biotechnol. 2005;23:1517-26.
63. Witvrouw M, Fikkert V, Pluymers W, Matthews B, Mardel K, Schols D, Raff J, Debyser Z, De Clercq E, Holan G, Pannecouque C. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle. Mol Pharmacol. 2000;58:1100-8.
64. Witvrouw M, Weigold H, Pannecouque C, Schols D, De Clercq E, Holan G. Potent anti-HIV (type 1 and type 2) activity of polyoxometalates: structure-activity relationship and mechanism of action. J Med Chem. 2000;43:778-83.
65. Nagahori N, Lee RT, Nishimura S, Page D, Roy R, Lee YC. Inhibition of adhesion of type 1 fimbriated Escherichia coli to highly mannosylated ligands. Chembiochem. 2002;3:836-44.
66. Heegaard PMH, Boas U. Dendrimer based anti-infective and anti-inflammatory drugs. Recent Pat Anti-Infect Drug Discovery. 2006;1:333-51.
67. Wiener EC, Brechbiel MW, Brothers H, Magin RL, Gansow OA, Tomalia DA, Lauterbur PC. Dendrimer-based metal chelates: A new class of magnetic resonance imaging contrast agents. Magn Res Med. 1994;31:1-8.
68. Kobayashi H, Kawamoto S, Jo SK, Bryant HL, Brechbiel MW, Star RA. Macromolecular MRI contrast agents with small dendrimers: Pharmacokinetic differences between sizes and cores. Bioconj Chem. 2003;14:388-94.
69. Tam JP. Synthetic peptide vaccine design, synthesis and properties of a high density multiple antigenic peptide system. Proc Natl Acad Sci USA. 1988;85:5409-13.
70. Ota S, Ono T, Morita A, Uenake A, Harada M, Nakayama E. Cellular processing of a multibranched lysine core with tumor antigen peptides and presentation of peptide epitopes recognized by cytotoxic T lymphocytes on antigen presenting cells. Cancer Res. 2002;62:1471-6.
71. Jiang DL, Aida T. A dendritic iron porphyrin as a novel haemoprotein mimic: Effects of the dendrimer cage on dioxygen-binding activity. Chem Commun. 1996;1523-4.
72. Dandliker PJ, Diederich F, Zingg A, Gisselbrecht JP, Gross M, Louati A, Sanford E. Dendrimers with porphyrin cores: Synthetic models for globular heme proteins. Helv Chim Acta. 1997;80:1773-801.
73. Singh P, Moll F, Lin SH, Ferzli C, Yu KS, Koski RK, Saul RG, Cronin P. Starburst dendrimers: enhanced performance and flexibility for immunoassays. Clin Chem. 1994;40:1845-9.
74. Singh P, Moll F, Lin SH, Ferzli C. Starburst dendrimers: a novel matrix for multifunctional reagents in immunoassays. Clin Chem. 1996;42:1567-9.
75. Ko EI. Aerogels as catalysts and catalyst supports. Chemtech. 1993;23:31-6.
76. Zhao MQ, Crooks RM. Homogeneous hydrogenation catalysis with monodisperse, dendrimer-encapsulated Pd and Pt nanoparticles. Angew Chem Int Ed. 1999;38:364-6.
77. Goetheer ELV, Baars MWPL, Van den Broeke LJP, Meijer EW, Keurentjes JTF. Functionalized poly(propylene imine) dendrimers as novel phase transfer catalysts in supercritical carbon dioxide. Ind Eng Chem Res. 2000;39:4634-40.
78. Astruc D, Chardac F. Dendritic catalysts and dendrimers in catalysis. Chem Rev. 2001;101:2991-3023.
79. Twyman LJ, King ASH, Martin IK. Catalysis inside dendrimers. Chem Soc Rev. 2002;31:69-82.
80. Martin M, Manea F, Fiammengo R, Prins LJ, Pasquato L, Scrimin P. Metallodendrimers as transphosphorylation catalysts. J Am Chem Soc. 2007;129:6982-3.
81. Ma H, Jen AKY. Functional dendrimers for non-linear optics. Adv Mater. 2001;13:1201-5.
82. Chang AC, Gillespie JB, Tabacco MB. Enhanced detection of live bacteria using a dendrimer thin film in an optical biosensor. Anal Chem. 2001;73:467-70.
83. Kawa M. Antenna effects of aromatic dendrons and their luminescence applications. Top Curr Chem. 2003;228:193-204.
84. Ophir F, Roey JA, Doron S, Joseph K. Some new aspects of dendrimer applications. J Lumin. 2005;111:315-25.
85. Neofotistou E, Demadis KD. Use of antiscalants for mitigation of silica (SiO2) fouling and deposition: fundamentals and applications in desalination systems. Desalination. 2004;167:257-72.
86. Santos DS, Cardoso MR, Leite FL, Aroca RF, Mattoso LHC, Oliveira ON, Mendoncua CR. The role of azopolymer/dendrimer layer-by-layer film architecture in photoinduced birefringence and the formation of surface-relief gratings. Langmuir. 2006;22:6177-80.
87. Bertorelle F, Lavabre D, Forgues SF. Dendrimer-tuned formation of luminescent organic microcrystals. J Am Chem Soc. 2003;125:6244-53.
88. Bertorelle F, Rodrigues F, Forgues SF. Dendrimer-tuned formation of fluorescent organic microcrystals: Influence of dye hydrophobicity and dendrimer charge. Langmuir. 2006;22:8523-31.
89. Diallo MS, Balogh L, Shafagati A, Johnson JH, Goddard WA, Tomalia DA. Poly(amidoamine) dendrimers: A new class of high capacity chelating agents for Cu(II) ions. Environ Sci Technol. 1999;33:820-4.
90. Diallo MS, Christie S, Swaminathan P, Johnson JH, Goddard WA. Dendrimer enhanced ultrafiltration: Recovery of Cu(II) from aqueous solutions using PAMAM dendrimers with ethylene diamine core and terminal NH2 groups. Environ Sci Technol. 2005;39:1366-77.
91. Pellechia PJ, Gao J, Gu Y, Ploehn HJ, Murphy CJ. Platinum ion uptake by dendrimers: An NMR and AFM study. Inorg Chem. 2004;43:1421-28.
92. Xu Y, Zhao D. Removal of copper from contaminated soil by use of poly(amidoamine) dendrimers. Environ Sci Technol. 2005;39:2369-75.
93. Barth RF, Adams DM, Soloway AH, Alam F, Darby MV. Boronated starburst dendrimer-monoclonal antibody immunoconjugates: Evaluation as a potential delivery system for neutron capture therapy. Bioconj Chem. 1994;5:58-66.
94. Wu G, Barth RF, Yang W, Chatterjee M, Tjarks W, Ciesielski MJ, Fenstermaker RA. Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy. Bioconj Chem. 2004;15:185-94.
95. Shcharbin D, Bryszewska M. Complex formation between endogenous toxin bilirubin and polyamidoamine dendrimers: a spectroscopic study. Biochim Biophys Acta. 2006;1760:1021-6.
96. Roberts JC, Bhalgat MK, Zera RT. Preliminary biological evaluation of polyaminoamine (PAMAM) starburst dendrimers. J Biomed Mater Res. 1996;30:53-65.
97. Wilbur D, Pathare P, Hamlin D, Bhular K, Vessela R. Biotin reagents for antibody pretargeting: Synthesis, radioiodination, and evaluation of biotinylated starburst dendrimers. Bioconj Chem. 1998;9:813-25.
98. Brazeau GA, Attia S, Poxon S, Hughes JA. In vitro myotoxicity of selected cationic macromolecules used in non-viral gene delivery. Pharm Res. 1998;15:680-4.
99. Supattapone S, Nguyen HB, Cohen FE, Prusiner SB, Scott MR. Elimination of prions by branched polyamines and implications for therapeutics. Proc Natl Acad Sci USA. 1999;96:14529-34.
100. Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, Meijer EW, Paulus W, Duncan R. Dendrimers: relationship between structure and biocompatibility in vitro and preliminary studies on the biodistribution of 25I labeled polyamidoamine dendrimers in vivo. J Control Rel. 2000;65:133-48.
101. Zinselmeyer BH, Mackay SP, Schatzlein AG, Uchegbu IF. The lower-generation polypropyleneimine dendrimers are effective gene-transfer agents. Pharmacol Res. 2002;19:960-7.
102. El-Sayed M, Ginski M, Rhodes C, Ghandehari H. Transepithelial transport of polyamidoamine dendrimers across Caco-2 cell monolayers. J Control Rel. 2002;81:355-65.
103. Jevprasesphant R, Penny J, Attwood D, McKeown NB, D'Emanuele A. Engineering of dendrimer surfaces to enhance transepithelial transport and reduce cytotoxicity. Pharm Res. 2003;20:1543-50.
104. Hong SP, Bielinska AU, Mecke A, Keszler B, Beals JL, Shi XY, Balogh L, Orr BG, Baker JR, Holl MMB. Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport. Bioconj Chem. 2004;15:774-82.
105. Mecke A, Uppuluri S, Sassanella TM, Lee DK, Ramamoorthy A, Baker JR, Orr BG, Holl MMB. Direct observation of lipid bilayer disruption by poly(amidoamine) dendrimers. Chem Phy Lipids. 2004;132:3-14.
106. Cakara D, Kleimann J, Borkovec M. Microscopic protonation equilibria of poly(amidoamine) dendrimers from macroscopic titrations. Macromolecules. 2003;36:4201-7.
107. Johnston TP, Kuchimanchi KR, Alur H, Chittchang M, Mitra AK. Inducing a change in the pharmacokinetics and biodistribution of poly-L-lysine in rats by complexation with heparin. J Pharm Pharmacol. 2003;55:1083-90.
108. Dash PR, Read ML, Barrett LB, Wolfert MA, Seymour LW. Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene Ther. 1999;6:643-650.
109. Gajbhiye V, Kumar PV, Tekade RK, Jain NK. Pharmaceutical and biomedical potential of PEGylated dendrimers. Curr Pharm Des. 2007;13:415-29.
110. Haba Y, Harada A, Takagishi T, Kono K. Synthesis of biocompatible dendrimers with a peripheral network formed by linking of polymerizable groups. Polymer. 2005;46:1813-20.
111. Hawker CJ, Fréchet JMJ. Preparation of polymers with controlled molecular architecture a new convergent approach to dendritic macromolecules. J Am Chem Soc. 1990;112:7638-47.
112. Ihre HR, De Jesus OLP, Szoka FC, Fréchet JMJ. Polyester dendritic systems for drug delivery applications: Design, synthesis, and characterization. Bioconj Chem. 2002;13:443-52.
113. Padilla De Jesus OL, Ihre HR, Gagne L, Fréchet JMJ, Szoka FC. Polyester dendritic systems for drug delivery applications: In vitro and in vivo evaluation. Bioconj Chem. 2002;13:453-61.
114. Zhang W, Jiang J, Qin C, Perez LM, Parrish AR, Safe SH, Simanek EE. Triazine dendrimers for drug delivery: evaluation of solubilization properties, activity in cell culture, and in vivo toxicity of a candidate vehicle. Supramol Chem. 2003;15:607-16.
115. Domaski DM, Bryszewska M, Salamoczyk G. Preliminary evaluation of the behavior of fifth-generation thiophosphate dendrimer in biological systems. Biomacromolecules. 2004;5:2007-12.
116. Shao J, Tam JP. Unprotected peptides as building blocks for the synthesis of peptide dendrimers with oxime, hydrazone, and thiazolidine linkages. J Am Chem Soc. 1995;117:3893-99.
117. Kim Y, Zeng FW, Zimmerman SC. Peptide dendrimers from natural amino acids. Chem Eur J. 1999;5:2133-38.
118. Dhanikula RS, Hildgen P. Synthesis and evaluation of novel dendrimers with a hydrophilic interior as nanocarriers for drug delivery. Bioconj Chem. 2006;17:29-41.
119. Darabantu M, Pintea M, Fazekas M, Lameiras P, Berghian C, Delhom I, Dumitrescu IS, Ple N, Turck A. First synthesis of a G-2 melamine dendrimer with serinolic peripheral groups. Lett Org Chem. 2006;3:905-10.
120. Nguyen PM, Hammond PT. Amphiphilic linear-dendritic triblock copolymers composed of poly(amidoamine) and poly(propylene oxide) and their micellarphase and encapsulation properties. Langmuir. 2006;22:7825-32.
121. Liu M, Kono K, Fréchet JMJ. Water-soluble unimolecular micelles: Their potential as drug delivery agents. J Control Rel. 2000;65:121-31.
122. Sideratou Z, Tsiourvas D, Paleos CM. Solubilization and release properties of PEGylated diaminobutane poly(propylene imine) dendrimers. J Colloid Interface Sci. 2001;242:272-6.
123. Quintana A, Raczka E, Piehler L, Lee I, Myc A, Majoros I, Patri AK, Thomas T, Mule J, Baker JR. Design and function of a dendrimer based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res. 2002;19:1310-16.
124. Mitchell JP, Roberts KD, Langley J, Koentegen F, Lambert JN. A direct method for the formation of peptide and carbohydrate dendrimers. Bioorg Med Chem Lett. 1999;9:2785-8.
125. Arima H, Kihara F, Hirayama F, Uekama K. Enhancement of gene expression by polyamidoamine dendrimer conjugates with α-, β- and γ-cyclodextrins. Bioconj Chem. 2001;12:476-84.
126. Woller EK, Cloninger MJ. Mannose functionalization of a sixth generation dendrimer. Biomacromolecules. 2001;2:1052-4.
127. Bhadra D, Yadav AK, Bhadra S, Jain NK. Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. Int J Pharm. 2005;295:221-33.
128. Ashton P, Boyd S, Brown C, Nepogodier S, Meijer E. Peerlings H, Stoddart J. Synthesis of glycodendrimers by modification of poly(propylene imine) dendrimers. Chem Eur J. 1997;3:974-84.
129. Agashe HB, Babbar AK, Jain S, Sharma RK, Mishra AK, Asthana A, Garg M, Dutta T, Jain NK. Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers. Nanomed Nanotech Biol Med. 2007;3:120-7.
130. Tung CH, Weissleder R. Arginine containing peptides as delivery vectors. Adv Drug Deliv Rev. 2003;55:281-94.
131. Henry M. Breaching barriers. Chem Eng News. 2003;81:35-43.
132. Kawase M, Kurikawa N, Higashiyama S, Miura N, Shiomi T, Ozawa C, Mizoguchi T, Yagi K. Effectiveness of polyamidoamine dendrimers modified with tripeptide growth factor, glycyl-L-histidyl-L-lysine, for enhancement of function of hepatoma cells. J Biosci Bioeng. 1999;88:433-7.
133. Okuda T, Sugiyama A, Niidome T, Aoyagi H. Characters of dendritic poly(L-lysine) analogues with the terminal lysines replaced with arginines and histidines as gene carriers in vitro. Biomaterials. 2004;25:537-44.
134. Choi JS, Nam K, Park J, Kim J, Lee J, Park J. Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine. J Control Rel. 2004;99:445-56.
135. Kono K, Akiyama H, Takahashi T, Takagishi T, Harada A. Transfection activity of polyamidoamine dendrimers having hydrophobic amino acid residues in the periphery. Bioconj Chem. 2005;16:208-14.
136. Shukla R, Thomas TP, Peters J, Kotlyar A, Myc A, Baker JR. Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates. Chem Commun. 2005;5739-41.
137. Kim T, Baek J, Bai CZ, Park J. Arginine-conjugated polypropyleneimine dendrimer as a non-toxic and efficient gene delivery carrier. Biomaterials. 2007;28:2061-7.
138. Bhadra D, Bhadra S, Jain NK. PEGylated dendritic nanoparticulate carriers of anti-cancer drugs. In: Amiji MM, editor. Nanotechnology for cancer therapy. 1st ed. Boca Raton: CRC Press; 2006. p.523-49.
139. Yang H, Lopina ST. Extended release of a novel antidepressant, venlafaxine, based on anionic polyamidoamine dendrimers and poly(ethylene glycol) containing semi-interpenetrating networks. J Biomed Mater Res A. 2005;72:107-14.
140. Choi JS, Lee EJ, Choi YH, Jeong YJ, Park JS. Poly(ethylene glycol)-block-poly(L-lysine) dendrimer: Novel linear polymer/dendrimer block copolymer forming a spherical water-soluble polyionic complex with DNA. Bioconj Chem. 1999;10:62-5.
141. Gillies ER, Fréchet JMJ. Designing macromolecules for therapeutic applications: Polyester dendrimers poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture. J Am Chem Soc. 2002;124:14137-46.
142. Paleos CM, Tsiourvas D, Sideratou Z, Tziveleka L. Acid and salt-triggered multifunctional poly(propylene imine) dendrimer as a prospective drug delivery system. Biomacromolecules. 2004;5:524-29.
143. Chen HT, Neerman MF, Parrish AR, Simanek EE. Cytotoxicity, haemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery. J Am Chem Soc. 2004;126:10044-48.
144. Yang H, Morris JJ, Lopina ST. Polyethylene glycol-polyamidoamine dendritic micelle as solubility enhancer and the effect of the length of polyethylene glycol arms on the solubility of pyrene in water. J Colloid Interface Sci. 2004;273:148-54.
145. Okuda T, Kawakami S, Akimoto N, Niidome T, Yamashita F, Hashida M. PEGylated lysine dendrimers for tumor-selective targeting after intravenous injection in tumor-bearing mice. J Control Rel. 2006;116:330-36.
146. Yam CM, Deluge M, Tang D, Kumar A, Cai C. Preparation, characterization, resistance to protein adsorption, and specific avidin-biotin binding of poly(amidoamine) dendrimers functionalized with oligo(ethylene glycol) on gold. J Colloid Interface Sci. 2006;296:118-30.
147. Wang S, Low PS. Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. J Control Rel. 1998;53:39-48.
148. Choi Y, Thomas T, Kotlyar A, Islam MT, Baker JR. Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting. Chem Biol. 2005;12:35-43.
149. Thomas TP, Patri AK, Myc A, Myaing MT, Ye JY, Norris TB, Baker JR. In vitro targeting of synthesized antibody-conjugated dendrimer nanoparticles. Biomacromolecules. 2004;5:2269-74.
150. Shukla R, Thomas TP, Peters JL, Desai AM, Latallo JFK, Patri AK, Kotlyar A, Baker JR. HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb. Bioconj Chem. 2006;17:1109-15.
151. Papagiannaros A, Dimas K, Papaioannou GT, Demetzos C. Doxorubicin-PAMAM dendrimer complex attached to liposomes: cytotoxic studies against human cancer cell lines. Int J Pharm. 2005;302:29-38.
152. Wagner E, Ogris M, Zauner W. Polylysine-based transfection systems utilizing receptor-mediated delivery. Adv Drug Deliv Rev. 1998;30:97-113.
153. Adcock IM, Caramori G. Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol Cell Biol. 2001;79:376-84.
154. Choi JS, Ko KS, Park J, Kim YH, Kim SW, Lee M. Dexamethasone conjugated poly(amidoamine) dendrimer as a gene carrier for efficient nuclear translocation. Int J Pharm. 2006;320:171-8.
155. Patel D, Henry J, Good T. Attenuation of beta-amyloid induced toxicity by sialic acid conjugated dendrimeric polymers. Biochim Biophys Acta. 2006;1760:1802-09.
156. Majoros IJ, Thomas TP, Mehta CB, Baker JR. Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. J Med Chem. 2005;48:5892-99.
157. Majoros IJ, Myc A, Thomas TP, Mehta CB, Baker JR. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: Synthesis, characterization, and functionality. Biomacromolecules. 2006;7:572-79.
158. Myc A, Majoros IJ, Thomas TP, Baker JR. Dendrimer-based targeted delivery of an apoptotic sensor in cancer cells, Biomacromolecules. 2007;8:13-18.
159. Schatzlein AG, Zinselmeyer BH, Elouzi A, Dufes C, Chim YTA, Roberts CJ, Davies MC, Munro A, Gray AI, Uchegbu IF. Preferential liver gene expression with polypropyleneimine dendrimers. J Control Rel. 2005;101:247-58.
160. Margerum LD, Campion BK, Koo M, Shargill N, Lai JJ, Marumoto A, Sontum PC. Gadolinium(III) DO3A macrocycles and polyethylene glycol coupled to dendrimers effect of molecular weight on physical and biological properties of macromolecular magnetic resonance imaging contrast agents. J Alloys Compd. 1997;249:185-90.
161. Tziveleka LA, Psarra AM, Tsiourvas D, Paleos CM. Synthesis and characterization of guanidinylated poly(propylene imine) dendrimers as gene transfection agents. J Control Rel. 2007;117:137-46.
162. Shaunak S, Thomas S, Gianasi E, Godwin A, Jones E, Teo I, Mireskandari K, Luthert P, Duncan R, Patterson S, Khaw P, Brocchini S. Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation. Nat Biotechnol. 2004;22:977-84.
163. Cho SY, Allcock HR. Dendrimers derived from polyphosphazene- poly(propylene imine) systems: Encapsulation and triggered release of hydrophobic guest molecules. Macromolecules. 2007;40:3115-21.
164. Baars MWPL, Keppinger R, Koch MHJ, Yeu SL, Meijer EW. The localization of guests in water soluble oligoethyleneoxy-modified poly(propylene imine) dendrimers. Angew Chem Int Ed. 2000;39:1285-88.
165. Dutta T, Agashe HB, Garg M, Balasubramanium P, Kabra M, Jain NK. Poly (propylene imine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro. J Drug Targeting. 2007;15:89-98.
166. Fahmy TM, Schneck JP, Saltzman WM. A nanoscopic multivalent antigen-presenting carrier for sensitive detection and drug delivery to T Cells. Nanomed Nanotech Biol Med. 2007;3:75-85.
167. Grosshans H. Gene therapy-when a simple concept meets a complex reality, review on gene therapy. Funct Integr Genomics. 2000;1:142-145.
168. Rolland AP. From genes to gene medicines: Recent advances in nonviral gene delivery. Crit Rev Ther Drug Carr Syst. 1998;15:143-98.
169. Roessler BJ, Bielinska AU, Janczak K, Lee I, Baker JR. Substituted β-cyclodextrins interact with PAMAM dendrimer-DNA complexes and modify transfection efficiency. Biochem Biophys Res Commun. 2001;283:124-129.
170. Arima H, Chihara Y, Arizono M, Yamashita S, Wada K, Hirayama F, Uekama K. Enhancement of gene transfer activity mediated by mannosylated dendrimer/alpha cyclodextrin conjugate (generation 3, G3). J Control Rel. 2006;116:64-74.
171. Kim JB, Choi JS, Nam K, Lee M, Park JS, Lee JK. Enhanced transfection of primary cortical cultures using arginine-grafted PAMAM dendrimer, PAMAM-Arg. J Control Rel. 2006;114:110-17.
172. Devarakonda B, Hill RA, De Villiers MM. The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine. Int J Pharm. 2004;284:133-40.
173. Devarakonda B, Li N, De Villiers MM. Effect of polyamidoamine (PAMAM) dendrimers on the in vitro release of water insoluble nifedipine from aqueous gels. AAPS Pharm Sci Tech. 2005;6:E504-12.
174. Chapman TM, Hillyer GL, Mahan EJ, Shaffer KA. Hydraamphiphiles: novel linear dendritic block copolymer surfactants. J Am Chem Soc. 1994;116:11195-96.
175. Khopade AJ, Caruso F, Tripathi P, Nagaich S, Jain NK. Effect of dendrimer on entrapment and release of bioactive from liposomes. Int J Pharm. 2002;232:157-62.
176. Lee H, Lim YB, Choi JS, Lee Y, Kim TI, Kim HJ, Yoon JK, Kim K, Park JS. Polyplexes assembled with internally quaternized PAMAM-OH dendrimer and plasmid DNA have a neutral surface and gene delivery potency. Bioconj Chem. 2003;14:1214-21.
177. Duncan R, Izzo L. Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev. 2005;57:2215-37.
178. Gillies ER, Dy E, Fréchet JMJ, Szoka FC. Biological evaluation of polyester dendrimer: Poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture. Mol Pharm. 2005;2:129-38.
179. Lee CC, Gillies ER, Fox ME, Guillaudeu SJ, Fréchet JMJ, Dy EE, Szoka FC. A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas. Proc Natl Acad Sci USA. 2006;103:16649-54.
180. Okuda T, Kawakami S, Maeie T, Niidome T, Yamashita F, Hashida M. Biodistribution characteristics of amino acid dendrimers and their PEGylated derivatives after intravenous administration. J Control Rel. 2006;114:69-77.
181. Latallo JFK, Candido KA, Cao Z, Nigavekar SS, Majoros IJ, Thomas TP, Balogh LP, Khan MK, Baker JR. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 2005;65:5317-24.
182. Hong S, Leroueil PR, Majoros IJ, Orr BG, Baker JR, Holl MMB. The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem Biol. 2007;14:107-15.
183. Pan G, Lemmouchi Y, Akala EO, Bakare O. Studies on PEGylated and drug-loaded PAMAM dendrimers. J Bioact Compat Polym. 2005;20:113-28.
184. Bhadra D, Bhadra S, Jain NK, editors. PEGylated-poly-L-lysine dendrimers for delivery of chloroquine phosphate. Proceedings of the 2004 International Conference on MEMS, NANO and Smart Systems;2004 Aug 25-27; Banff, Alberta, Canada. IEEE Computer Society; 2004.
185. Bourne N, Stanberry LR, Kern ER, Holan G, Matthews B, Bernstein DI. Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection. Antimicrob Agents Chaemother. 2000;44:2471-74.
186. Landers JJ, Cao Z, Lee I, Piehler LT, Myc PP, Myc A, Hamouda T, Galecki AT, Baker JR. Prevention of influenza pneumonitis by sialic acid-conjugated dendritic polymers. J Infect Dis. 2002;186:1222-30.
187. Chen CZS, Cooper SL. Recent advances in antimicrobial dendrimers. Adv Mater. 2000;12:843-46.
188. Chen CZS, Cooper SL. Interactions between dendrimer biocides and bacterial membranes. Biomaterials. 2002;23:3359-68.
189. Chen CZS, Tan NCB, Dhurjati P, Van Dyk TK, LaRossa RA, Cooper SL. Quaternary ammonium functionalized poly(propylene imine) dendrimers as effective antimicrobials: Structure-activity studies. Biomacromolecules. 2000;1:473-80.
190. Thomas TP, Majoros IJ, Kotlyar A, Latallo JFK, Bielinska A, Myc A, Baker JR. Targeting and inhibition of cell growth by an engineered dendritic nanodevice. J Med Chem. 2005;48:3729-35.
191. Tono Y, Kojima C, Haba Y, Takahashi T, Harada A, Yagi S, Kono K. Thermosensitive properties of poly(amidoamine) dendrimers with peripheral phenylalanine residues. Langmuir. 2006;22:4920-22.
192. Haba Y, Kojima C, Harada A, Kono K. Control of temperature-sensitive properties of poly(amidoamine) dendrimers using peripheral modification with various alkylamide groups. Macromolecules. 2006;39:7451-53.
193. Tomalia DA, Swanson DR. Laboratory synthesis and characterization of megamers: Core-shell tecto(dendrimers). In: Fréchet JMJ, Tomalia DA, editors. Dendrimers and other dendritic polymers. 1st ed. UK: Wiley; 2001. p. 617-29.
194. Leung KCF, Arico F, Cantrill SJ, Stoddart JF. Dynamic Mechanically inter-locked dendrimers: amplification in dendritic dynamic combinatorial libraries. Macromolecules. 2007;40:3951-59.
195. Jain NK, Khopade AJ. Dendrimers as potential systems for bioactives. In: Jain NK, editor. Advances in controlled and targeted drug delivery. 1st ed. New Delhi: CBS Publishers and Distributors; 2001. p. 361-80.
196. Gupta U, Agashe HB, Asthana A, Jain NK. A review of in vitro-in vivo investigations on dendrimers: The novel nanoscopic drug carriers. Nanomed Nanotech Biol Med. 2006;2:66-73.